Cargando…

Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge

Lymphadenopathies can be part of the clinical spectrum of several primary immunodeficiencies, including diseases with immune dysregulation and autoinflammatory disorders, as the clinical expression of benign polyclonal lymphoproliferation, granulomatous disease or lymphoid malignancy. Lymphadenopath...

Descripción completa

Detalles Bibliográficos
Autores principales: Costagliola, Giorgio, Consolini, Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374228/
https://www.ncbi.nlm.nih.gov/pubmed/34008169
http://dx.doi.org/10.1111/cei.13620
_version_ 1783740070524616704
author Costagliola, Giorgio
Consolini, Rita
author_facet Costagliola, Giorgio
Consolini, Rita
author_sort Costagliola, Giorgio
collection PubMed
description Lymphadenopathies can be part of the clinical spectrum of several primary immunodeficiencies, including diseases with immune dysregulation and autoinflammatory disorders, as the clinical expression of benign polyclonal lymphoproliferation, granulomatous disease or lymphoid malignancy. Lymphadenopathy poses a significant diagnostic dilemma when it represents the first sign of a disorder of the immune system, leading to a consequently delayed diagnosis. Additionally, the finding of lymphadenopathy in a patient with diagnosed immunodeficiency raises the question of the differential diagnosis between benign lymphoproliferation and malignancies. Lymphadenopathies are evidenced in 15–20% of the patients with common variable immunodeficiency, while in other antibody deficiencies the prevalence is lower. They are also evidenced in different combined immunodeficiency disorders, including Omenn syndrome, which presents in the first months of life. Interestingly, in the activated phosphoinositide 3‐kinase delta syndrome, autoimmune lymphoproliferative syndrome, Epstein–Barr virus (EBV)‐related lymphoproliferative disorders and regulatory T cell disorders, lymphadenopathy is one of the leading signs of the entire clinical picture. Among autoinflammatory diseases, the highest prevalence of lymphadenopathies is observed in patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) and hyper‐immunoglobulin (Ig)D syndrome. The mechanisms underlying lymphoproliferation in the different disorders of the immune system are multiple and not completely elucidated. The advances in genetic techniques provide the opportunity of identifying new monogenic disorders, allowing genotype–phenotype correlations to be made and to provide adequate follow‐up and treatment in the single diseases. In this work, we provide an overview of the most relevant immune disorders associated with lymphadenopathy, focusing on their diagnostic and prognostic implications.
format Online
Article
Text
id pubmed-8374228
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83742282021-08-24 Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge Costagliola, Giorgio Consolini, Rita Clin Exp Immunol Review Lymphadenopathies can be part of the clinical spectrum of several primary immunodeficiencies, including diseases with immune dysregulation and autoinflammatory disorders, as the clinical expression of benign polyclonal lymphoproliferation, granulomatous disease or lymphoid malignancy. Lymphadenopathy poses a significant diagnostic dilemma when it represents the first sign of a disorder of the immune system, leading to a consequently delayed diagnosis. Additionally, the finding of lymphadenopathy in a patient with diagnosed immunodeficiency raises the question of the differential diagnosis between benign lymphoproliferation and malignancies. Lymphadenopathies are evidenced in 15–20% of the patients with common variable immunodeficiency, while in other antibody deficiencies the prevalence is lower. They are also evidenced in different combined immunodeficiency disorders, including Omenn syndrome, which presents in the first months of life. Interestingly, in the activated phosphoinositide 3‐kinase delta syndrome, autoimmune lymphoproliferative syndrome, Epstein–Barr virus (EBV)‐related lymphoproliferative disorders and regulatory T cell disorders, lymphadenopathy is one of the leading signs of the entire clinical picture. Among autoinflammatory diseases, the highest prevalence of lymphadenopathies is observed in patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) and hyper‐immunoglobulin (Ig)D syndrome. The mechanisms underlying lymphoproliferation in the different disorders of the immune system are multiple and not completely elucidated. The advances in genetic techniques provide the opportunity of identifying new monogenic disorders, allowing genotype–phenotype correlations to be made and to provide adequate follow‐up and treatment in the single diseases. In this work, we provide an overview of the most relevant immune disorders associated with lymphadenopathy, focusing on their diagnostic and prognostic implications. John Wiley and Sons Inc. 2021-06-20 2021-09 /pmc/articles/PMC8374228/ /pubmed/34008169 http://dx.doi.org/10.1111/cei.13620 Text en © 2021 The Authors. Clinical & Experimental Immunology published by John Wiley & Sons Ltd on behalf of British Society for Immunology https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Review
Costagliola, Giorgio
Consolini, Rita
Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
title Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
title_full Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
title_fullStr Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
title_full_unstemmed Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
title_short Lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: An intriguing challenge
title_sort lymphadenopathy at the crossroad between immunodeficiency and autoinflammation: an intriguing challenge
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8374228/
https://www.ncbi.nlm.nih.gov/pubmed/34008169
http://dx.doi.org/10.1111/cei.13620
work_keys_str_mv AT costagliolagiorgio lymphadenopathyatthecrossroadbetweenimmunodeficiencyandautoinflammationanintriguingchallenge
AT consolinirita lymphadenopathyatthecrossroadbetweenimmunodeficiencyandautoinflammationanintriguingchallenge